Last reviewed · How we verify
NCT04996147: F4T
Acute and Long-term Impact of Cancer Treatment on Head and Neck Cancer Patients: FIT4TREATMENT
trial in Head and Neck Neoplasms in 21 participants. Terminated before completion.
3 March 2020
Quick facts
| Lead sponsor | Associacao de Investigacao de Cuidados de Suporte em Oncologia |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 21 |
| Start date | 1 June 2019 |
| Primary completion | 3 March 2020 |
| Estimated completion | 3 March 2020 |
| Sites | 1 location across Portugal |
Conditions studied
- Head and Neck Neoplasms — all drugs for Head and Neck Neoplasms →
Sponsor
Associacao de Investigacao de Cuidados de Suporte em Oncologia
Who can join
18 and older, any sex, with Head and Neck Neoplasms. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Head and Neck Squamous Cell Carcinoma (HNSCC) is the 6th most common cancer. Most cases are diagnosed in locally advanced stages, with treatment involving multimodal approach with combinations of radiotherapy, surgery and chemotherapy. The aggressive nature of HNSCCs and treatment modalities are associated with important acute and late toxicities that often promote temporary or definitive treatment interruption and may compromised the capability to tolerate subsequent treatments. Thus, the aim of this study is to analyze the acute and long-term impact of cancer treatment on quality of life, physical and cognitive function of HNSCC patients diagnosed with a locally advanced disease.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Acute Impact of Cancer Treatment on Head and Neck Cancer Patients: FIT4TREATMENT.
Leão I, Garcia C, Antunes P, Campolargo A, et al · · 2022 · cited 5× · PMID 35681678 · DOI 10.3390/cancers14112698
Verify or expand the search:
- PubMed search for NCT04996147
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Head and Neck Neoplasms
Currently open trials in the same condition.
- NCT07491536 — Ozone Therapy With Biomimetic Oral Care for Cancer-Related Oral Mucositis · NA · recruiting
- NCT06912087 — Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC · Phase 1 · recruiting
- NCT06998069 — Head and Neck Cancer Study Project in the Geriatric Population · Phase 3 · recruiting
- NCT07158164 — DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment · Phase 4 · recruiting
- NCT06303180 — NIDCD Otolaryngology Clinical Protocol Biospecimen Bank · recruiting
Other Associacao de Investigacao de Cuidados de Suporte em Oncologia trials
Trials by the same sponsor.
- NCT05132998 — Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors · NA · completed
- NCT05418842 — Exercise Prehabilitation in Patients With Head and Neck Squamous-cell Carcinoma: The FIT4TREAT Trial · NA · completed
- NCT05071560 — Physical Exercise for Breast Cancer Survivors: Face-to-face Versus Home-based · NA · completed
- NCT04710472 — MentorApp for Cancer Patient's Remote Monitoring · Phase 2 · unknown
- NCT04572282 — Mobile App for Symptoms Monitoring in Cancer Patients: a Pilot Study · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04996147 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Associacao de Investigacao de Cuidados de Suporte em Oncologia
- Last refreshed: 9 August 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04996147.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing